Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Heegaard

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Acta Diabetologica|August 11, 2022
Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patientsAnne Suhr Thykjær, N Andersen, T Bek, et al.
The British Journal of Ophthalmology|May 5, 2006
Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force studyL D Sjö, E Ralfkiaer, B R Juhl, et al.
Clinical Genetics|September 17, 2014
A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinomaK A W Wadt, L G Aoude, P Johansson, et al.
ESMO Open|April 22, 2026
Uveal melanoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upS Piperno-Neumann, M Angi, P A Ascierto, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Acta Diabetologica|August 11, 2022
Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patientsAnne Suhr Thykjær, N Andersen, T Bek, et al.
The British Journal of Ophthalmology|May 5, 2006
Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force studyL D Sjö, E Ralfkiaer, B R Juhl, et al.
Clinical Genetics|September 17, 2014
A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinomaK A W Wadt, L G Aoude, P Johansson, et al.
ESMO Open|April 22, 2026
Uveal melanoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upS Piperno-Neumann, M Angi, P A Ascierto, et al.
Pageof 6